Topoisomerase-targeting Agents
The invention provides compounds of formula I or formula II: wherein: the bond represented by
is a single bond or a double bond, and R1-R5, X, and Y have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I or II, processes for preparing compounds of formula I or II, intermediates useful for preparing compounds of formula I or II, and therapeutic methods for treating cancer and other topoisomerase related conditions using compounds of formula I or II.
Attached files:Patents:US 20,090,258,890
Inventor(s):
LAVOIE EDMOND J [US]; RUCHELMAN ALEXANDER L [US]; LIU LEROY F [US]
Type of Offer:
Licensing
« More Biotech Patents